LENZ Therapeutics, Inc.LENZNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank0
Studio
Year-over-Year Change

Year-over-year research & development expense growth

Percentile
P0
Near historical low
vs 3Y Ago
-0.2x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2024-49.92%
2023181.68%
2022-44.31%
2021315.78%
20200.00%
20190.00%